reviewNature MedicineSep 1, 2019Closed access

Clinical lessons learned from the first leg of the CAR T cell journey

RGRobbie G. MajznerCLCrystal L. Mackall

Cancer Prevention Institute of California · Stanford Cancer Institute · +2 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

619
total citations
FWCI
30.40
Percentile
100%
References
147
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • Chimeric antigen receptor
  • Clinical trial
  • Food and drug administration
  • Medicine
  • Disease
  • CAR T-cell therapy
  • Cancer
  • Cell therapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding